Lemonex

Developer of drug delivery technology and biosensor technology

placeSeoul, Seoul, South Korea calendar_todayFounded 2013 groups9 employees language lemonexbio.com

Registered entities

Innovation

41 patent families (13 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 1,060 times.

YearFilings
20151
20164
20174
20187
201912
202019
202116
202219
202313
20248
202510

Investor mix

14 investors on record; lead investors include Union Investment Partners.

Investor typeCountShare
Venture capital750%
Private equity17%
Bank & private debt17%
Other / undisclosed536%
Coming soon